A detailed history of Lindbrook Capital, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 190 shares of ORGO stock, worth $1,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190
Previous 190 -0.0%
Holding current value
$1,179
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$2.42 - $3.24 $1,430 - $1,914
-591 Reduced 75.67%
190 $0
Q2 2024

Jul 31, 2024

BUY
$2.28 - $3.03 $1,780 - $2,366
781 New
781 $2,000
Q3 2023

Oct 25, 2023

BUY
$2.34 - $4.43 $985 - $1,865
421 Added 57.28%
1,156 $3,000
Q2 2023

Jul 28, 2023

BUY
$1.9 - $4.3 $900 - $2,038
474 Added 181.61%
735 $2,000
Q1 2023

Apr 26, 2023

BUY
$1.89 - $2.93 $493 - $764
261 New
261 $0
Q3 2022

Nov 10, 2022

BUY
$3.14 - $6.43 $204 - $417
65 New
65 $0

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $813M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.